Clinical Trial: Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951945) titled 'Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity' on April 23.

Brief Summary: The aim of this trial is to investigate the safety, tolerability, pharmacokinetics, and efficacy of THDBH120 injection in participants with obesity. This study includes three multiple-ascending dose cohorts.

Study Start Date: July 18, 2024

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DRUG: THDBH120 injection

Participants received THDBH120 by subcutaneous injection.

DRUG: Placebo of THDBH120 injection

Participants received placebo by subcutaneous in...